ARTICLE
|
doi:10.20944/preprints202312.0594.v1
Subject:
Medicine And Pharmacology,
Neuroscience And Neurology
Keywords:
neuromyelitis optica disorder; anti-aquaporin-4; anti-myelin oligodendrocyte glycoprotein; rituximab; serious infection
Online: 8 December 2023 (09:59:09 CET)